N/A
N=798
Communicating Risk Information for Obesity
Obesity
Bottom Line
View on ClinicalTrials.gov: NCT01355224 ↗Enrolled (actual)
798
Serious AEs
0.0%
Results posted
Mar 2017
Primary outcome: Primary: Intentions to Lose Weight - Effect of Study Arm on Outcomes — 3.06; 3.37; 3.26; 3.26 units on a scale — p=.0150
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Genetic (Genetic); Lifestyle (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Boston University
- Primary completion
- Sep 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Intentions to Lose Weight - Effect of Study Arm on Outcomes |
3.06; 3.37; 3.26; 3.26 | .0150 sig |
| PRIMARY Intention to Lose Weight - Impact of Risk Status |
3.05; 3.38; 3.35; 3.38; 3.19 | 0.0365 sig |
| PRIMARY Intention to Lose Weight - Combined Risk |
3.08; 3.38; 3.12; 3.24; 3.37 | 0.0622 |
Summary
This study will examine the impact of providing genetic risk information for obesity on people's attitudes and beliefs about obesity, health behaviors and weight outcomes. Specifically, this study will examine the feasibility of using genetic information to motivate efforts to reduce obesity among individuals recruited to the Coriell Personalized Medicine Collaborative (CPMC), see below for description of CPMC.
Eligibility Criteria
Inclusion Criteria
Must be age 18 or older, active enrollees in the CPMC trial, and able to read and write in English.
Exclusion Criteria
Individuals that do not meet the inclusion criteria.
Data sourced from ClinicalTrials.gov (NCT01355224). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.